BJCT-BIOJECT-needle less injection product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: novice investor who wrote (36)	8/27/1997 8:15:00 AM
From: geewiz	of 534

Hey NI, I doubt there is a BJCT shareholder who has not been too optimistic! Not a one of us anticipated the protracted marketing misteps and failures. Speaking for myself I continue to hold for the same reasons I made an initial commitiment; the company has the only vaccine injection product that replaces the needle and provides a package solution. No matter which bio-tech drugs winn out, BJCT has the potential to be the delivery vector. I am sorry to hear of your loss; I too have a significant paper loss, fortunately I am not in retirement and counting on the money for expenses. Until I find the company to be less than honest I will hope for the best. As for the additional registration, I will look into it. My best is that the previous June registration is the shares distributed to Schering. I found an interesting interview with CEO of Medi-ject that covers some interesting material; mktnews.nasdaq.com best, art

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next